Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

The essential SARS-CoV-2 3CL protease is of interest as a drug target. Here, the authors identify three 3CL inhibitors and characterize them both in vitro and with a cell-based assay, and they also present the inhibitor-bound 3CL crystal structures, which may allow for the design of improved compoun...

Full description

Bibliographic Details
Main Authors: Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R. Stockwell, Alejandro Chavez, David D. Ho
Format: Article
Language:English
Published: Nature Portfolio 2021-04-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-021-22362-2

Internet

https://doi.org/10.1038/s41467-021-22362-2

Similar Items